Episode Details

Is Europe finally moving from cannabis liberalisation to professionalisation? This week we break down Germany’s BaFin tightening capital rules, the UK’s first NHS-dispensed cannabis prescription, and a pharmaceutical milestone that could redefine chronic-pain care. We also track new German cultivation applicants (and funding), PHCANN’s pharma-grade push, and why Brazil’s ANVISA delays still keep 670,000+ patients dependent on imports.TDR Weekly International Recap presented by Prohibition Partners. From prospectuses and audits in Germany to a whole-plant drug nearing market approval (VER-01), we look at how stricter standards may accelerate investment and physician adoption. The UK’s quiet shift inside the NHS hints at broader prescribing comfort, while PHCANN’s EU-GMP approach underscores traceability and stability. Meanwhile, Brazil’s stalled cultivation rules remain a cautionary tale: without domestic supply, access and affordability stay out of reach. Like, subscribe, and drop your take—does professionalisation help or hinder patient access?#CannabisNews #ProhibitionPartners #EuropeanCannabis #GermanyBaFin #MarijuanaRescheduling #MedicalCannabis #CannabisPharma #Vertanical #CannabisReform #BrazilCannabisWant to see more Cannabis Reform videos?   • Trump's 60-Day Cartel War Could Reshape Ca...     • Cannabis Stock BREAKTHROUGH on Robinhood |...     • Ron DeSantis Admits Voters Want Cannabis —...     • Virginia Governor Race: Cannabis Takes Cen...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:

Listen Now